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A B S T R A C T
Several neurodegenerative diseases like Huntington's, a polyglutamine (PolyQ) disease, are initiated by protein
aggregation in neurons. Furthermore, these diseases are also associated with a multitude of responses in non-
neuronal cells in the brain, in particular glial cells, like astrocytes. These non-neuronal responses have repeatedly
been suggested to play a disease-modulating role, but how these may be exploited to delay the progression of
neurodegeneration has remained unclear. Interestingly, one of the molecular changes that astrocytes undergo
includes the upregulation of certain Heat Shock Proteins (HSPs) that are classically considered to maintain
protein homeostasis, thus resulting in cell autonomous protection. Previously, we discovered DNAJB6, a member
of the human DNAJ family, as potent cell autonomous suppressor of PolyQ aggregation and related neurode-
generation. Using cell type speciﬁc expression systems in D. melanogaster, we show that exclusive expression of
DNAJB6 in astrocytes (that do not express PolyQ protein) can delay neurodegeneration and expands lifespan
when the PolyQ protein is exclusively expressed in neurons (that do not co-express DNAJB6 themselves). This
provides direct evidence for a non-cell autonomous protective role of astrocytes in PolyQ diseases.
1. Introduction
Heat Shock Proteins (HSPs) are key regulators of the cellular protein
quality control (PQC) system (Hartl et al., 2011). In addition to their
roles in protein folding, protein transport and protein complex re-
modelling, HSPs have also been implied in the disaggregation, as well
as in the degradation of un- or misfolded proteins (Kakkar et al., 2014).
Many age-related neurodegenerative diseases (NDs) are characterized
by protein aggregates in neurons and these are thought to initiate or
drive their pathology and degeneration (Kakkar et al., 2014; Kampinga
and Bergink, 2016).
These ﬁndings have led to the speculation that an age-related de-
cline in PQC may be key to disease initiation (Balch et al., 2008) and
also suggested that boosting the (selective) activity of components of
the cellular PQC such as HSPs may hold promises for counteracting NDs
(Kakkar et al., 2014; Kampinga and Bergink, 2016; Balch et al., 2008).
In line with these hypotheses, we and others have performed several
forward genetic screens to identify speciﬁc HSPs within the PQC net-
work that may serve to prevent the aggregation of disease-related
proteins and thereby delay the onset of NDs (Hageman et al., 2011; Vos
et al., 2010; Hageman et al., 2010; Kakkar et al., 2016a). In such
screens, we identiﬁed DNAJB6, a human HSP of the DNAJ family and
HSP70 co-chaperone, as a very potent and cell autonomous inhibitor of
protein aggregation in diﬀerent in vitro and in vivo models of PolyQ
diseases (Hageman et al., 2011; Kakkar et al., 2016b), including Hun-
tington's disease (HD, OMIM:#143100), which is characterized by the
aggregation of mutant PolyQ Huntingtin (HTT). DNAJB6 is a ubiqui-
tously expressed and non-stress-regulated co-chaperone of HSP70 that
forms highly dynamic oligomers (Hageman et al., 2011; Kakkar et al.,
2016b). It can bind to early intermediates (but not to monomers) of
PolyQ containing peptides that initiate ﬁbril formation via direct in-
teraction to the amyloidogenic core (i.e. the polyQ sequence) of poly-
glutamine containing protein ﬁbrils, thus potently preventing primary
nucleation and (to a lesser extent) also secondary nucleation (Kakkar
et al., 2016b; Gillis et al., 2013; Månsson et al., 2014). DNAJB6 diﬀers
from other HSPs (such as HSP70 and DNAJB1) that cannot suppress
aggregation by the core PolyQ peptide, although they can act on se-
quences ﬂanking the amyloidogenic PolyQ core (Hageman et al., 2011;
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Månsson et al., 2014). In line, DNAJB6 has been shown to inhibit ag-
gregation not only of PolyQ HTT, but also of PolyQ ATXN3 and PolyQ
androgen receptor (Hageman et al., 2010). This speciﬁc function of
DNAJB6 is dependent on a unique S/T-rich region in DNAJB6, which is
exposed on the DNAJB6 surface and where the amyloid-forming pep-
tides can bind (Kakkar et al., 2016b; Söderberg et al., 2018; Månsson
et al., 2018). In addition to protein aggregation, a common hallmark of
nearly all aggregation-related NDs is the reactivity of astrocytes, a
speciﬁc type of glial cells that normally contributes to the brain
homeostasis and supports the neuronal functions (Sofroniew and
Vinters, 2010). The astrocytic response during aggregation-related NDs
is found in degenerating areas of the brain and is characterized by a
spectrum of progressive molecular, cellular and functional changes
(Sofroniew and Vinters, 2010; Ben Haim et al., 2015), which are most
likely a response triggered by the neuronal damage. On one hand, the
(early) astrocytic response has repeatedly been suggested to serve in a
protective manner to counteract the progression of neurodegeneration.
On the other hand, (chronic) astrocytic reactivity has also been sug-
gested to be a maladaptive response that leads to disease aggravation
(Sofroniew, 2009).
Interestingly, one of the molecular changes detected in astrocytes in
human brains aﬀected by neurodegeneration includes the up-regulation
of certain HSPs (Durrenberger et al., 2009; Seidel et al., 2012;
Wilhelmus et al., 2006; Dabir et al., 2004), including DNAJB6
(Durrenberger et al., 2009). However, the functional implications of
HSPs-up-regulations for the progression of neuronal degeneration have
not yet been established.
To fully explore whether and how the expression of HSPs con-
tributes to neuroprotection in NDs, we generated D.melanogastermodels
that exclusively express PolyQ-HTT in neurons, whilst co-expressing
human DNAJB6 either in the same neurons (to study cell autonomous
eﬀects) or in astrocytes (to study non-cell autonomous eﬀects).
Our studies show that human DNAJB6 can provide cell autonomous
protection against PolyQ mediated neurodegeneration in
D.melanogaster, which is associated with a reduction in the PolyQ-HTT
aggregate load in ﬂy brains. Strikingly, the exclusive expression of
DNAJB6 in astrocytes also provides non-cell autonomous protection
against progressive neuronal degeneration and prolongs organismal
Fig. 1. Protective activity of DNAJB6 against PolyQ-HTT-mediated degeneration in D. melanogaster ommatidia. A) Representative images of eyes in 48 h old
adult male ﬂies expressing the indicated transgenes in ommatidia. mCD8-GFP is a reporter for ommatidia integrity. Genotypes in Materials and Methods. B)
Quantiﬁcation of the corrected mean eye ﬂuorescence (CMEF) for mCD8-GFP of Fig. 1A. Statistical signiﬁcance was analysed using 10 eyes/group with 1-way
ANOVA test (SEM, ***, p < 0.001). C) Western Blots of total head lysates of 48 h old adult female ﬂies expressing the indicated transgenes in ommatidia. Anti-
huntingtin antibody used for detection of monomers (100 kDa), cleaved products (70 kDa), intermediate aggregated species (130–170 kDa) and HMW aggregates
(stacking gel) of HttQ100-mRFP. Anti-GFP antibody used for mCD8-GFP detection. Anti-V5 antibody for (V5 tagged) DNAJB6 detection. Tubulin was used as loading
control. Number of ﬂy heads per each lysate sample and genotypes in Materials and Methods. D) Quantiﬁcation of HMW aggregates of HttQ100-mRFP (signal in
stacking gel) and mCD8-GFP of data of Fig. 1C (signal normalized on tubulin; a.u.: arbitrary units).
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lifespan, although not accompanied by a reduction in the PolyQ-HTT
aggregate load in the ﬂy brains. Rather, under these conditions, in ﬂies
that express DNAJB6 in astrocytes, a high fraction of astrocytes now
contain neuronal derived PolyQ-HTT aggregates, in line with the sug-
gestion that astrocytes might take up prion-like PolyQ-HTT aggregates
species, a capacity that is enhanced by DNAJB6 expression (Brundin
et al., 2010; Costanzo and Zurzolo, 2013; Ren et al., 2009; Babcock and
Ganetzky, 2015).
2. Materials and methods
2.1. Vectors
UAS/LexO vectors were obtained by cloning the sequences of
HttQ100-mRFP (Prof. T. Littleton Group, MIT) or V5-DNAJB6 (isoform
B) or eGFP (Clontech) in the multiple cloning site of pUAS attB or
pLexO attB (Prof. K. Basler Group, UZH). Driver (Promoter cell-speciﬁc
expression) vectors were obtained starting from the backbone of plas-
mids pDPP-Gal4 attB or pDPP-LG attB or pDPP-LhG attB (Prof. K. Basler
Group, UZH). DPP promoter was substituted with the sequence of
promoter elav (pan-neuronal, from pElav-Casper vector, Prof. Liqun
Luo, Stanford University), repo (pan-glial, from pENTRY-D-TOPO-
Repo4.3 vector, Prof. C. Klämbt, University of Münster) or alrm (as-
trocytic, from pAlrm-Casper vector, Prof. M. Freeman, UMASS). All
obtained vectors were sequenced. See Table T1 for vectors list.
2.2. D. melanogaster stocks
The D. melanogaster lines of Table T1 were obtained by injection and
transformation of embryos with the above mentioned attB vectors,
based on attP-site speciﬁc PhiC31 integrase system, by Best Gene Inc.
injection service. D. melanogaster lines from Bloomington Drosophila
Stock Center were also used: gmr-Gal4 (Line BDSC #8121 in Fig. 1);
gmr-Gal4 (Line BDSC #1104 in Fig. S1-1); alrm-Gal4 (Line BDSC
#67031 in Fig. S1-1); UAS-mCD8-GFP (Line BDSC #5130); UAS-mCD8-
RFP (Line BDSC #27391); UAS-ATXN3-Q78 (Line BDSC #8150 in Fig.
S1-1); gmr-QF2 (Line BDSC #59283 in Fig. S1-1 was a gift from C.
Potter, Baltimore, MD, U.S.A.). gmr-QF2 and QUAS-ATXN3-Q78 are
based on the Q expression system in D.melanogaster (Potter et al., 2010).
All the lines were isogenised to remove background mutations by
backcrossing each of them for 6 generations with the control stock
w1118 line.
2.3. Genotypes
Fig. 1: w(−); UAS HttQ100-mRFP / + (or UAS DNAJB6); gmr Gal4 /
UAS mCD8-GFP (or +). Fig. S1-1: for cell-autonomous rescue: w(−);
gmr-Gal4:UAS ATXN3-Q78/ UAS DNAJB6 (or +); +/+. For non-cell
autonomous rescue: w(−),gmr-QF2; alrm-Gal4:QUAS ATXN3-Q78/ UAS
DNAJB6 (or +); +/+. Fig. 2A, S2-1A: w(−); UAS HttQ100-mRFP (or
UAS eGFP) / +; elav Gal4/+. Fig. 3B and S3-1H: 1) Control line (red):
w(−); UAS HttQ100-mRFP / elav LhG; elav Gal4 / LexO eGFP. 2) Res-
cued line (blue): w(−); UAS HttQ100-mRFP / elav LhG; elav Gal4 / LexO
DNAJB6. Fig. S3-1B: 1) active combinations w(−); UAS eGFP (D) /+;
promoter Gal4/+. 2) inactive combinations: w(−); UAS eGFP/ promoter
LexA; +/+ or w(−); promoter Gal4/+; LexO eGFP (A) /+. Fig. S3-1C:
w(−); UAS eGFP/+; promoter Gal4/+ or w(−);promoter LexA (LG or
LhG)/+; LexO eGFP/+. Negative control: w(−);+/+;+/+. Fig. S3-
1D: w(−); UAS eGFP(D)/+; promoter Gal4/+ or w(−);promoter LexA
(LG or LhG)/+; LexO eGFP(A)/+. Negative control: w(−);+/+;+/+.
Fig. 4A and B: w(−); UAS mCD8-RFP(or UAS HttQ100-mRFP) / alrm
LhG; elav Gal4 / LexO eGFP. Fig. 5A and Fig. S5-1B: 1) control line (red):
w(−); UAS HttQ100-mRFP / promoter(repo or alrm) LhG; elav Gal4 /
LexO eGFP. 2) Rescued line (blue): w(−); UAS HttQ100-mRFP / pro-
moter (repo or alrm) LhG; elav Gal4 / LexO DNAJB6. Fig. 5B and Fig. S5-
1E: 1) Control (Fig. 5B, panel 1 and Fig. S5-1E, panels 1–3): w(−); UAS
CD8-mRFP / alrm LhG; elav Gal4 / LexO eGFP. 2) Condition 1 (Fig. 5B,
panel 2 and Fig. S5-1E, panels 4–6): w(−); UAS HttQ100-mRFP / alrm
LhG; elav Gal4 / LexO eGFP. 3) Condition 2 (Fig. 5B, panel 3 and Fig. S5-
1E, panels 7–9; Fig. 5C and Supplementary Movie M1): w(−); UAS
HttQ100-mRFP / alrm LhG; elav Gal4 / LexO DNAJB6. Fig. 5E and Fig.
S5-1H: 1) Control line (red): w(−); UAS HttQ100-mRFP / promoter (elav
or alrm) LhG; elav Gal4 / LexO eGFP. 2) Rescued line (blue): w(−); UAS
HttQ100-mRFP / promoter (elav or alrm) LhG; elav Gal4 / LexO DNAJB6.
Fig. S5-1F: w(−); UAS HttQ100-mRFP (or +) / +; elav Gal4/+.
2.4. Antibodies and reagents
Antibodies (dilutions are indicated in brackets for western blots
(WB) and immunoﬂuorescence (IF)) against huntingtin (Chemicon,
MAB2166, WB 1:5000), eGFP (Clontech-Living Colours, cat.No.632375,
WB 1:5000), α-tubulin (Sigma Aldrich, clone DM1A, WB 1:2000), V5
epitope tag in DNAJB6b (Thermo Fisher Scientiﬁc, cat. No.R960–25,
WB 1:2000, IF 1:50), NC-82 (DSHB, WB 1:5000) were used. DAPI for
nuclei staining (cat.No.D1306) was from Thermo Fisher Scientiﬁc. 20%
Fig. 2. Pan-Neuronal expression of PolyQ-HTT causes aggregate formation and reduces lifespan in D. melanogaster. A)Western Blots of total head lysates of 5
and 15-day-old adult male ﬂies expressing the indicated transgenes in all neurons. Anti-huntingtin antibody for detection of monomers (100 kDa), cleaved products
(70 kDa), intermediate aggregated species (130–170 kDa) and HMW aggregates (stacking gel) of HttQ100-mRFP. Tubulin was used as loading control. Number of ﬂy
heads per each lysate sample and genotypes in Materials and Methods. B) Lifespan of the same isogenised males ﬂies expressing HttQ100-mRFP or control transgene
(eGFP or only promoter) in all neurons. Lifespan of HttQ100-mRFP-expressing line (red curve) is signiﬁcantly reduced compared to the eGFP-expressing control line
(green curve). Detailed statistics, comparisons and genotypes are provided in Fig. S2-1B. (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
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SDS Solution (cat.No.1610418) was from BioRad. PBS components
(NaCl cat.No.S9888, KCl cat.No.P9541, Na2HPO4 cat.No.255793,
KH2PO4 cat.No.V000225), Tween-20 (cat.No.P2287), Triton X-100
(cat.No.T8787), Bovine Serum Albumin (cat.No.A2058, BSA), glycerol
(cat.No.G5516), 3.7% Formaldehyde (cat.No.11–0705 SAJ), Tris base
(cat.No.T1503) and β-mercaptoethanol (cat.No.M6250) were from
Sigma Aldrich.
2.5. D. melanogaster stocks maintenance
All stocks and experimental ﬂies were kept in polystyrene vials
25×95 mm ﬁlled with 8ml/vial of solidiﬁed media (17 g/l Agar; 26 g/
l Yeast; 54 g/l Sugar; 1.3mg/l Nipagin). All experimental ﬂies were
maintained in a humidiﬁed and temperature controlled incubator at
25 °C on a 12 h' light and 12 h' dark cycle (Premium ICH Insect
Chamber, Snijders Labs). Experimental ﬂies, anesthetized on a CO2
pad, were selected according to their gender and phenotype by light
microscope visualization.
2.6. Lifespan curves
Parental ﬂies (5–6 females and 5–6 males) were kept in vial for
3 days and then removed. Oﬀspring virgin ﬂies were collected in the
same 24 h. For each analysed group, ≈100 ﬂies of speciﬁc gender and
phenotype were collected and kept in new vials (10 ﬂies/vial). Flies
were transferred to new vials containing fresh medium every 2 days and
deaths were scored daily. Statistical signiﬁcance of curves diﬀerences
analysed with Log rank (Mantel-Cox) test (test 1) and Gehan-Breslow-
Wilcoxon test (test 2) using Graph Pad Prism Software Version 5.00. All
curves comparisons were made from ﬂies analysed in the same ex-
periment. T50 was deﬁned as the time point at which 50% of the initial
population has died.
2.7. Western Blotting D. melanogaster total head lysates preparation
30–40 D. melanogaster adults with speciﬁc phenotype, gender, age
(days after pupal eclosion) and condition were collected; after freezing
in liquid nitrogen and vortexing of entire ﬂies, separated heads were
collected, counted and lysed in SDS-rich buﬀer (SDS 1.45%, Glycerol
20%; Tris Base 0.2 M. 2.5 μl of buﬀer/head) using sonication (3 pulses
of 50W for 5 s). Homogenized lysate was then centrifuged at 1000 x g
for 3 s to separate cuticle debris from supernatant. Proteins in super-
natant were collected and quantiﬁed using spectrophotometry (Implant
NanoPhotometer UV/Vis). Protein content was equalized. Samples,
supplied with β-mercaptoethanol 5% and bromophenol blue, were
boiled at 99 °C for 5min. Equal amounts of volume were resolved on
SDS-PAGE. Flies of the same line were collected from diﬀerent vials and
the entire experiment was repeated at least 2 times.
2.8. Western Blotting and Blot quantiﬁcation
Following the preparation of samples, proteins were resolved by
SDS-PAGE, transferred to nitrocellulose membrane and processed for
Western Blotting. Primary antibodies (at concentrations mentioned
above) were prepared in 3% BSA/PBS-Tween 20 0.1%, secondary an-
tibodies at concentration 1:5000 (Invitrogen, horse peroxidase con-
jugated to IGG or IGM) in 5% milk/PBS-Tween 20 0.1%. For visuali-
zation membranes were incubated with Pierce ECL Western Blotting
substrate (cat. No. 32106) for 2min and visualized using ChemiDoc
Touch Imaging System (BioRad). Blots have been quantiﬁed using
Image Lab Version 5.2.1 software (BioRad).
2.9. Imaging of ﬂuorescent eyes in D.melanogaster and quantiﬁcation
Experimental D. melanogaster adults with speciﬁc phenotype,
gender, age (days after pupal eclosion) and condition were kept an-
esthetized on a CO2 pad and their GFP ﬂuorescent eyes were visualized
Fig. 3. Eﬀect of neuronal DNAJB6 expression on PolyQ-HTT aggregate formation and lifespan in a pan-neuronal HttQ100-mRFP D. melanogastermodel. A)
Lifespan of isogenised male ﬂies co-expressing neuronal (N>) HttQ100-mRFP and neuronal (N>) DNAJB6 or eGFP. Lifespan of DNAJB6-expressing line (blue
curve) is signiﬁcantly expanded compared to the control line (red curve). Additional control lines, comparisons, statistics and genotypes are provided in Fig. S3-1 E,
G. B)Western Blots of total head lysates of 5 and 15-day-old adult female ﬂies (with equal transgenes expression of ﬂies in Fig. 3A). Anti-huntingtin antibody used for
detection of monomers (100 kDa), cleaved products (70 kDa), intermediate aggregated species (130–170 kDa) and HMW aggregates (stacking gel) of HttQ100-mRFP.
Anti-V5 antibody for (V5 tagged) DNAJB6 detection. Anti-GFP antibody for eGFP detection. Tubulin was used as loading control. HMW aggregates of HttQ100-mRFP
quantiﬁcation (signal in stacking gel normalized on tubulin signal; a.u.: arbitrary units) for each line is shown. Number of ﬂy heads per each lysate sample and
genotypes in Materials and Methods. An independent repeat of the experiment is shown in Fig. S3-1H. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article.)
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using Leica MZ10 F Fluorescence stereomicroscope (GFP3 ﬁlter). 10
eyes of diﬀerent ﬂies / group were visualized and GFP ﬂuorescence was
quantiﬁed using Image J 1.48v software and expressed as corrected
mean eye ﬂuorescence (CMEF). CMEF has been calculated as:
Integrated Density - (Selected Area x Mean Background Fluorescence).
Statistical signiﬁcance of CMEF diﬀerences analysed with 1-way
ANOVA test using Graph Pad Prism Software Version 5.00.
2.10. Analysis of eye degeneration at light microscope
For each condition, at least 80 ﬂy eyes were checked. The fraction of
the eyes that showed degeneration phenotype were calculated as
previously (Vos et al., 2010). For each analysed line, eyes of at least 40
ﬂies were scored. The results were average of at least three independent
experiments.
2.11. D.melanogaster Immunoﬂuorescence (IF), Imaging and Punctae
Quantiﬁcation
Brains of experimental D. melanogaster adults with speciﬁc pheno-
type, gender, age (days after pupal eclosion) and condition were dis-
sected by light microscope visualization, in 0.1% Triton X-100 PBS 1×
buﬀer and then ﬁxed in 3.7% Formaldehyde, 0.1% Triton X-100 PBS
1× buﬀer for 20min at room temperature. Staining of brains was
Fig. 4. Eﬀects of glial or astrocytic DNAJB6 expression on lifespan in a pan-neuronal HttQ100-mRFP D. melanogaster model. A,B) Representative confocal
images of brains from 15-day-old adult male ﬂies co-expressing transgenes in diﬀerent cell types using the two independent expression systems: mCD8-RFP (Fig. 4A)
or HttQ100-mRFP (Fig. 4B) in all neurons and eGFP in astrocytes. Neuronal lobes and regions rich of HttQ100-mRFP punctae are shown. In the detail of the merged
image of Fig. 4A, astrocytes (closed circles) with their processes (arrows) are indicated. In the detail of the merged image of Fig. 4B, neurons bodies (dashed circles)
with HttQ100-mRFP punctae (arrows) and astrocytes (closed circles) are indicated. Scale bar: 100 μm. Magniﬁcation: 20×. Genotypes in Materials and Methods. C,
D) Lifespan of isogenised male ﬂies co-expressing neuronal (N>) HttQ100-mRFP with either glial (G>) DNAJB6 or eGFP (Fig. 4C) or astrocytic (A>) DNAJB6 or
eGFP (Fig. 4D). Lifespan of DNAJB6-expressing line (blue curve) is signiﬁcantly expanded compared to the control line (red curve) both for Fig.4C and Fig.4D.
Additional control lines, comparisons, statistics and genotypes are provided in Fig. S4-1 B,C and F. (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)
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performed by blocking not speciﬁc sites using 2% BSA, 0.1% Triton X-
100 PBS 1× buﬀer for 30min at room temperature, then incubating
with primary antibody (dilution 1:50) in blocking buﬀer for 2 days at
4 °C and ﬁnally with secondary Alexa-conjugated dyes antibody
(Invitrogen, Alexa Fluor 488 goat-anti-mouse; dilution 1:500) and DAPI
(ﬁnal concentration 0.2 μg/μl) in blocking buﬀer for 2 days at 4 °C, to
respectively visualize primary antibodies and nuclei. Brains were
mounted between glass slide and coverslip, embedded in mountant
solution (CitiFluor, Agar Scientiﬁc) and visualized by confocal micro-
scopy within 24 h. IF images of D.melanogaster brains were captured
using confocal laser scanning microscope (Leica TCS SP8). Z-stack
images were obtained to check for the punctae in cells at diﬀerent Z-
planes. Quantiﬁcation of the punctae in cells was carried out manually.
Photoshop, and Image J software were used for image processing and to
generate the 3D reconstruction (Supplementary Movie M1). Statistical
signiﬁcance of values diﬀerences analysed with 1-way ANOVA test
using Graph Pad Prism Software Version 5.00.
3. Results
In order to test whether and how the expression of HSPs in astro-
cytes might be relevant for neuroprotection in PolyQ diseases, we
decided to use DNAJB6, one of the most potent human chaperones in
providing protection against these diseases in diﬀerent in vitro and in
vivo models (Hageman et al., 2010; Kakkar et al., 2016b).
We ﬁrst veriﬁed whether this protective function of human DNAJB6
against PolyQ aggregation was also maintained in D. melanogaster. To
do so, we ﬁrst used the ommatidia integrity of transgenic D. melano-
gaster lines as readout for PolyQ-mediated degeneration. Hereto, the
construct HttQ100-mRFP (encoding for human PolyQ-HTT exons 1–12;
Weiss et al., 2012) was expressed in ﬂy ommatidia together with human
DNAJB6 (short nuclear and cytosolic isoform B; Hanai and Mashima,
2003) and the membrane-targeted mCD8-GFP (a quantiﬁable ﬂuor-
escent reporter of internal ommatidia integrity, established and vali-
dated in diﬀerent D.melanogaster ommatidia-models of PolyQ diseases;
Burr et al., 2014), using the gmr promoter driven by the Gal4-UAS ex-
pression system (Brand and Perrimon, 1993). The sole expression of
HttQ100-mRFP caused a signiﬁcant reduction in mCD8-GFP ﬂuores-
cence in ommatidia (Fig. 1A, B) and in total mCD8-GFP protein levels
(Fig. 1C, D), indicating the degeneration of ommatidia. Both endpoints
were alleviated by co-expression of DNAJB6 in the same cells (Fig. 1A-
D), which implies a cell-autonomous protective eﬀect of this HSP
against HttQ100-mRFP toxicity. Notably, HttQ100-mRFP aggregation
and mCD8-GFP levels are inversely correlated, further validating the
use of this reporter, and conﬁrming previous mechanistic ﬁndings that
DNAJB6 can directly prevent the aggregation of PolyQ proteins in a
cell-autonomous manner (Hageman et al., 2010; Kakkar et al., 2016b).
Comparable data were found when co-expressing DNAJB6 with a
truncated ataxin-3 (ATXN3) carrying an expanded PolyQ (ATXN3-Q78)
(Warrick et al., 1998), responsible for spinocerebellar ataxia type 3
(OMIM:#109150) (Costa and Paulson, 2012) (Fig. S1-1A). This con-
ﬁrms our previous ﬁndings that the protective action of DNAJB6 is
generic for the core PolyQ-expansion (Månsson et al., 2014) and in-
dependent from regions ﬂanking the PolyQ expansion for which it is
known that they can aﬀect the aggregation propensity of the PolyQ-
containing protein (Kuiper et al., 2017). In line with the protective
action against cell degeneration, DNAJB6 expression also resulted in a
reduction in the amount of HttQ100-mRFP aggregates in total head
lysates (Fig. 1C, D).
Next, we generated a D. melanogaster line expressing HttQ100-mRFP
in all neurons using the validated and well-characterized pan-neuronal
promoter elav-Gal4 (Yao et al., 1993). Western blots of total head ly-
sates showed abundant levels of HTT monomers, cleaved products,
aggregating intermediates and high molecular weight (HMW) HTT-
aggregates in 5-day-old adult male (Fig. 2A) and female (Fig. S2-1A)
ﬂies. In 15-day-old adults, monomers and other intermediate species
were remarkably decreased and HMW aggregates were still present,
indicating progressive aggregation and a worsening of the HD-pheno-
type. Lifespan analysis showed a signiﬁcant reduction in lifespan of
HttQ100-mRFP expressing males (Fig. 2B), with a T50 decrease of 55%
(Fig. S2-1B; a comparable eﬀect has been also observed in females, data
not shown).
Subsequently, we used the GAL4-UAS and LexA-LexO (Yagi et al.,
2010) expression systems that can drive expression of transgenes in a
completely independent and non-overlapping manner (Fig. S3-1A-D).
We generated lines co-expressing HttQ100-mRFP regulated by GAL4-
UAS and DNAJB6 by LexA-LexO, solely in neurons (using the elav
promoter). Neuronal expression of DNAJB6 extended the lifespan of
ﬂies co-expressing neuronal HttQ100-mRFP, increasing the T50 by 43%
(Fig. 3A, Fig. S3-1G). The line co-expressing neuronal eGFP and
HttQ100-mRFP showed a lifespan comparable to that of ﬂies expressing
neuronal HttQ100-mRFP only (compare Fig. 2B, Fig. S2-1B with
Fig. 3A, Fig. S3-1E, G). This indicates that combined use of multiple
promoters and eGFP expression was without any biological con-
sequences, meaning that the lifespan reduction in the line co-expressing
neuronal eGFP and HttQ100-mRFP of Fig. 3A is primarily due to the
expression of the toxic PolyQ protein. Expression of DNAJB6 in neurons
of control ﬂies did not result in lifespan modulating eﬀects (Fig. S3-1F,
G), indicating that the protection in the PolyQ model is not due to a
non-speciﬁc ﬁtness-enhancing eﬀect of DNAJB6. Again, in line with the
previous observations (Hageman et al., 2010; Kakkar et al., 2016b) and
the data on D.melanogaster eyes-degeneration (Fig. 1), we found that
Fig. 5. Eﬀect of glial or astrocytic DNAJB6 expression in the pan-neuronal HttQ100-mRFP D. melanogaster model on aggregates formation, aggregate
distribution within the brain and overall neuronal ﬁtness. A) Western Blots of total head lysates of 5 and 15-day-old adult female ﬂies co-expressing neuronal
(Neur.>) HttQ100-mRFP and glial (Glial > , lines 1–4) or astrocytic (Astr. > , lines 5–8) DNAJB6 or eGFP. Anti-huntingtin antibody used for detection of monomers
(100 kDa), cleaved products (70 kDa), intermediate aggregated species (130–170 kDa) and HMW aggregates (stacking gel) of HttQ100-mRFP. Anti-V5 antibody for
(V5 tagged) DNAJB6 detection. Anti-GFP antibody for eGFP detection. Tubulin was used as loading control. HMW aggregates of HttQ100-mRFP quantiﬁcation
(signal in stacking gel normalized on tubulin signal; a.u.: arbitrary units) for each line is shown. Number of ﬂy heads per each lysate sample and genotypes in
Materials and Methods. An independent repeat of the experiment is shown in Fig. S5-1B. B) Representative confocal images of brains from 15-day-old adult male ﬂies
co-expressing neuronal mCD8-RFP or HttQ100-mRFP and astrocytic DNAJB6b or eGFP. For each indicated condition, a representative picture of the region in central
brain indicated in Fig. S5-1D is shown. In panels 1–3, detailed images are provided showing astrocytes (closed circles) and HttQ100-mRFP punctae in astrocytes
(arrows), used for the counting in Fig. 5D. Anti-V5 antibody and Alexa488 secondary antibody were used for (V5 tagged) DNAJB6 detection. Scale bar: 25 μm.
Magniﬁcation: 40×. Genotypes in Materials and Methods. C) Frames from the representative Movie M1 (3D confocal image reconstruction) at diﬀerent time points,
showing astrocytes expressing DNAJB6b and containing HttQ100-mRFP puncta (arrows) from 15-day-old adult male ﬂies expressing the indicated transgenes.
Frames show the same cells from diﬀerent angles. Anti-V5 antibody and Alexa488 secondary antibody were used for (V5 tagged) DNAJB6 detection. Magniﬁcation:
63×. Genotypes in Materials and Methods. D) Percentage of green ﬂuorescent astrocytes containing HttQ100-mRFP puncta in a confocal section of brains from ﬂies
of Fig. 5B and Fig. S5-1E (2 brains, 20 sections per condition). Statistical signiﬁcance analysed with 1-way ANOVA test (SEM, ***, p < 0,001). E) Western blots of
NC82 from total head lysates of 5 and 15-day-old adult female ﬂies co-expressing neuronal (Neur.>) HttQ100-mRFP and neuronal (Neur.>) or astrocytic (Astr. >)
DNAJB6 or eGFP. Anti-NC82 antibody for NC82. Tubulin was used as loading control. Number of ﬂy heads per each lysate sample and genotypes in Materials and
Methods. An independent repeat of the experiment is shown in Fig. S5-1H. F) Quantiﬁcation of NC82 of data in Fig. 5E at day 15 (signal normalized on tubulin; a.u.:
arbitrary units). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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neuronal expression of DNAJB6 also reduced the amount of HttQ100-
mRFP aggregates in total head lysates (Fig. 3B, Fig. S3-1H). Together
these data imply and conﬁrm that DNAJB6 has a speciﬁc and cell-au-
tonomous protective activity against HttQ100-mRFP mediated toxicity
in neurons that is associated with its ability to reduce PolyQ aggregate
formation (Månsson et al., 2014). Notably, brain cell degeneration due
to HttQ100-mRFP toxicity might lead to reduce expression of the var-
ious transgenes during the time and disease progression, but this does
not change the overall conclusion of the above described experiments.
Astrocytes have been suggested to play a key role in many ag-
gregate-related NDs, including HD (Sofroniew and Vinters, 2010; Ben
Haim et al., 2015). On the one hand, it has been suggested that the
neuronal damage leads to astrocyte reactivity, which compromises their
functions in nourishing and protecting neurons. On the other hand, data
from rodent HD models and indirect evidence derived from human HD
brains (Jansen et al., 2016) suggested that PolyQ-HTT may also be di-
rectly toxic to astrocytes, thus contributing to their chronic reactivity
and to a neurodegenerative phenotype. In line with these ﬁndings and
those from rodent models expressing PolyQ-HTT in astrocytes (Shin
et al., 2005; Bradford et al., 2009), we observed that the selective ex-
pression of HttQ100-mRFP in the astrocytes of D. melanogaster (using
the validated and characterized astrocyte-speciﬁc alrm-Gal4 promoter;
Doherty et al., 2009) reduced the lifespan of the cohort (Fig. S4-1A, F).
Astrocytes are generally considered to be more resistant to PolyQ-
HTT aggregation and toxicity than neurons (Jansen et al., 2014; Jansen
et al., 2016) and hence PolyQ diseases are primarily thought to be due
to neuronal dysfunction and death. Moreover, although chronic astro-
cyte reactivity is considered to be detrimental, the initial astrocytic
responses have been suggested to actually counteract the progression of
neurodegeneration. However, direct evidence to substantiate this hy-
pothesis is lacking. Importantly, altered expression of several HSPs in
astrocytes are amongst such molecular changes (Durrenberger et al.,
2009; Seidel et al., 2012; Wilhelmus et al., 2006; Dabir et al., 2004), the
relevance of which has not been demonstrated so far.
Having established that the neuronal cell-autonomous protection of
human DNAJB6 is recapitulated in the D.melanogaster system, we ad-
dressed whether the up-regulation of chaperones, like DNAJB6, in as-
trocytes might non-cell autonomously protect neurons against PolyQ
mediated degeneration. To test this hypothesis, we selectively ex-
pressed DNAJB6 in astrocytes (using the speciﬁc promoter alrm-LexA;
Doherty et al., 2009), or in all glial cells (using the pan-glial promoter
repo-LexA; Xiong et al., 1994), in the ﬂies co-expressing HttQ100-mRFP
in neurons (Fig. S3-1A-D and Fig. 4). Whereas PolyQ-HTT is ubiqui-
tously expressed in HD human brains and rodent models of HD like R6/
2 mice, in our ﬂy model the PolyQ protein, HttQ100-mRFP, is ex-
clusively expressed in neurons, but not in astrocytes or glial cells
(Fig. 4): this enabled us to exclusively investigate whether astrocytic/
glial DNAJB6 expression might exert non-cell autonomous protective
eﬀects against the toxicity mediated by the PolyQ proteins expressed in
neurons. The tissue speciﬁc-expression via each of these promoters was
conﬁrmed by confocal microscopic analysis: control brains with mCD8-
RFP in neurons and eGFP in astrocytes show non-overlapping staining
as evidenced by diﬀuse mCD8-RFP ﬂuorescence in neuronal lobes (e.g.
antennal lobes, mushroom bodies), surrounded by a network of eGFP-
positive astrocytes with ramiﬁed processes (Fig. 4A). Staining of brains
of ﬂies expressing neuronal HttQ100-mRFP was slightly lower.
HttQ100-mRFP foci reminiscent of aggregate formation, were mainly
detected in the neurons (Fig. 4B).
Strikingly, the exclusive expression of DNAJB6 in all glial cells
signiﬁcantly expanded the lifespan of ﬂies expressing pan-neuronal
HttQ100-mRFP, increasing the T50 by 23% (Fig. 4C, Fig. S4-1B, F). In
fact, the exclusive expression of DNAJB6 in astrocytes only resulted in a
similar lifespan extension in ﬂies expressing pan-neuronal HttQ100-
mRFP (25%, Fig. 4D, Fig. S4-1C, F), indicating that the expression of
DNAJB6 in this speciﬁc type of glial cells alone suﬃces to provide non-
cell autonomous protection against PolyQ mediated toxicity. The
lifespan extension in these lines is also not as pronounced as observed
when DNAJB6 is expressed in neurons (in which T50 is increased by
43%; Fig. 3A, Fig. S3-1G), suggesting that the pro-survival mechanisms
mediated by DNAJB6 expression in diﬀerent cell types might be me-
chanistically distinct and not completely equal in terms of eﬀectiveness.
Similar to what we found for exclusive DNAJB6 expression in neurons,
DNAJB6 expression in all glial cells (Fig. S4-1D, F) or astrocytes (Fig.
S4-1E, F) did not aﬀect lifespan in control ﬂies, indicating its speciﬁc
eﬀect on HttQ100-mRFP related toxicity. In a similar approach, we also
found that DNAJB6 expression in astrocytes alleviated the level of eye
degeneration caused by expression of ATXN3-Q78 in ﬂy ommatidia
(Fig. S1-1B).
In order to investigate the mechanism underlying this non-cell au-
tonomous protection, we ﬁrst considered the possibility of intercellular
transmission of DNAJB6 from glial cells to neurons (Takeuchi et al.,
2015) (Fig. S5-1A). For this hypothesis to be true, such a transfer should
lead to reduced aggregation of HttQ100-mRFP, similar to what we
observed for the cell-autonomous protection via the expression of
DNAJB6 in neurons (Fig. 3B, Fig. S3-1H). However, DNAJB6 expression
in all glial cells or astrocytes was not associated with a comparable
dramatic reduction of HMW HttQ100-mRFP aggregates in total head
lysates (Fig. 5A, Fig. S5-1B). These data conﬁrm the speciﬁcity of the
used expression systems. More importantly, these data imply that the
intercellular glia-to-neurons transmission of DNAJB6 is unlikely the
only or the dominant mechanism for the non-cell autonomous protec-
tive eﬀects of DNAJB6 on the lifespan of neuronal HttQ100-mRFP ﬂies.
In view of these results, we next investigated if other additional pro-
survival and non-cell autonomous mechanisms would take place when
DNAJB6 is expressed in astrocytes. It has been suggested that PolyQ-
HTT aggregates may spread throughout the brain in a prion-like
manner (Brundin et al., 2010; Costanzo and Zurzolo, 2013; Ren et al.,
2009; Babcock and Ganetzky, 2015) (Fig. S5-1C) and that this pro-
gressive spread of disease-associated proteins contributes to the pro-
gression of the neurodegenerative process. In theory, astrocytes might
restrict such spreading via actively taking up prion-like protein species,
a capacity that might be limited by the progressive accumulation of
toxic aggregates (Pearce et al., 2015) (Fig. S5-1C). In line with this idea,
confocal microscopic analysis of ﬂies co-expressing neuronal HttQ100-
mRFP and astrocytic eGFP, revealed that approximately ~10% of eGFP-
expressing astrocytes, contained mRFP punctae (Fig. 5B, D; Fig. S5-1D,
S5-1E). These puncta are reminiscent of protein aggregation and under
all conditions are qualitatively associated with the relative amounts of
insoluble proteinaceous material detected in our western analyses. This
phenomenon was not due to indiscriminate protein transfer, as shown
by the absence of mRFP punctae in eGFP astrocytes of the control line
expressing neuronal non-aggregating membrane-bound mCD8-RFP
(Fig. 5B, D; Fig. 5D, E). These data support the hypothesis that PolyQ
HTT aggregates can indeed be transferred from neurons to astrocytes.
Importantly, the combined expression of neuronal HttQ100-mRFP with
astrocytic DNAJB6 resulted in a signiﬁcant increase in the frequency of
astrocytes with RFP punctae to ~50% (Fig. 5B-D; Fig. S5-1D, S5-1E),
suggesting that DNAJB6 expression positively inﬂuenced the capacity
of astrocytes of taking up such prion-like species (Fig. S5-1C). 3-D
confocal analyses conﬁrmed that HttQ100-mRFP aggregates are indeed
inside astrocytes (Fig. 5C, Supplementary Movie M1).To conﬁrm that
the expression of astrocytic DNAJB6 indeed resulted in the actual and
speciﬁc non-cell autonomous protection of neurons, we analysed the
level of the neuronal marker NC82 (Wagh et al., 2006) in total ﬂy head
lysates. NC82 (Bruchpilot) is a key synaptic protein for the activity and
integrity of the pre-synaptic zone in D.melanogaster brain (Wagh et al.,
2006). NC82 is critical for a normal-evoked neurotransmitter release at
the chemical synapses and, notably, the RNAi-induced-reduction of
neuronal NC82 expression leads to an alteration of the normal synaptic
components, to locomotor inactivity, and to unstable ﬂight in adult
D.melanogaster (Wagh et al., 2006). The expression level of NC82 pro-
vides therefore a direct measure of the functional ﬁtness of the neuronal
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population. We found NC82 levels to be strongly decreased in 15-day-
old ﬂies solely expressing neuronal HttQ100-mRFP (Fig. S5-1F, G). This
NC82-decline was not only alleviated in ﬂies co-expressing neuronal
DNAJB6 (cell autonomous protection), but also in ﬂies co-expressing
DNAJB6 in astrocytes (non-cell autonomous protection, Fig. 5E, F, Fig.
S5-1H, I), implying an overall improvement of overall neuronal ﬁtness
in both cases.
4. Discussion
Our data are a direct demonstration of a long-assumed hypothesis
that glial cells, and particular astrocytes, might play a modulating role
in HD, which as in many other NDs, initially and primarily aﬀects
neurons.
PolyQ-HTT is expressed in glial cells in the brain of HD patients and
animal models (Jansen et al., 2016). In line with previous data from
rodent models (Shin et al., 2005; Bradford et al., 2009), we conﬁrmed
that PolyQ-Htt exclusively expressed in astrocytes reduces lifespan in
D.melanogaster. These data thus indicate that astrocytic PolyQ-HTT may
contribute to HD pathology and that astrocytic damage is generally
detrimental to the health of the brain, as notably observed in Alexander
disease (OMIM:#203450), a genetic neurodegenerative disorder that
primarily aﬀects astrocytes by a dominant gain-of-function mutation of
the GFAP gene (Sofroniew and Vinters, 2010; Olabarria and Goldman,
2017).
However, our data revealing neuroprotection by expression of
DNAJB6 in astrocytes diﬀer from these latter studies (Jansen et al.,
2016; Shin et al., 2005; Bradford et al., 2009), as astrocytes in our D.
melanogaster model do not express PolyQ-HTT. Still, we found that
DNAJB6-expressing astrocytes provide a non-cell autonomous protec-
tive eﬀects against degeneration of neurons expressing PolyQ-HTT.
Thus, these data for the ﬁrst time reveal that astrocytes empowered
with suﬃcient chaperone activity, provided by DNAJB6, can provide
protection against degeneration of neurons in HD.
DNAJB6, the chaperone used in this study, has cell-autonomous
protective eﬀects as previously shown (Kakkar et al., 2016b), which are
strongly associated with its ability to prevent the initiation of PolyQ
aggregation by the core-polyQ fragment, irrespective of regions
ﬂanking the expansion (Hageman et al., 2010; Månsson et al., 2014),
for which it is known that they can aﬀect the aggregation propensity of
the PolyQ-containing protein (Kuiper et al., 2017). Our ﬁndings for
both in vivo PolyQ HTT and PolyQ ATXN3 ﬂy models show that also
not only the cell autonomous, but also the non-cell autonomous eﬀects
of DNAJB6 are generic for PolyQ proteins.
Interestingly, the non-cell autonomous protection evoked by
DNAJB6 expression in astrocytes is not associated with a reduction in
PolyQ-HTT aggregation. Although it has been suggested that DNAJs
and other HSPs can be transmitted between cells via exosomes
(Takeuchi et al., 2015), the absence of an eﬀect on total aggregate
formation in our study implies that additional mechanisms may un-
derlie the DNAJB6-mediated non-cell autonomous protection.
Despite the use of well-established promoters and two independent
expression systems, it could still be argued that low levels of neuronal
DNAJB6, due to an eventual leakage of the repo-LexA and alrm-LexA
promoters and beyond detection limit of our microscopic analyses,
could have been responsible for the observed protection evoked by
DNAJB6 expression in astrocytes. However, using a weaker elav pro-
moter to drive neuronal DNAJB6 expression than those used in the
presented data (i.e. using the elav-LG instead of the elav-LhG promoter
(Fig. S3-1A-D and Yagi et al., 2010)) we found no signiﬁcant cell au-
tonomous protection, whereas we could still detect neuronal DNAJB6
expression (data not shown). This implies that it is highly unlikely that
the observed protection by astrocytic DNAJB6 expression is due to
leakage of the repo-LexA and alrm-LexA promoters.
This implies that the observed non-cell autonomous protection via
astrocytic DNAJB6 expression is directly due to an activity of the
chaperone in the astrocytes enhancing its ﬁtness and function. We hy-
pothesize such may delay the trans-cellular spreading of PolyQ HTT
aggregates in the D.melanogaster brain. Cellular experiments have in-
deed demonstrated that PolyQ-HTT aggregates can enter cells where
they can initiate intracellular seeding (Kakkar et al., 2016b; Ren et al.,
2009) and can spread between neurons in the D.melanogaster brain
(Babcock and Ganetzky, 2015). Our data show that, in the same orga-
nismal system, these neuronal PolyQ-HTT aggregates can end up in
astrocytes in agreement with observations by Pearce and colleagues
(Pearce et al., 2015), using axotomised neurons. The uptake of neuron-
derived aggregates could imply that astrocytes act as a “reservoir” for
these toxic prion-like species, thereby preventing their neuron-to-
neuron spreading in the brain and hence delaying the progression of
neurodegeneration. The prion-reservoir capacity of astrocytes is likely
limited by the toxicity of captured aggregates. However, the upregu-
lation of chaperones like DNAJB6 may enhance this capacity, which is
supported by our data showing that the frequency of astrocytes with
inclusions is increased in case of DNAJB6 overexpression. This provokes
the speculation that DNAJB6 can positively inﬂuence the prion-re-
servoir capacity of astrocytes and their ability to prevent the spreading
of prion-like species in the brain, via its protective functions against
PolyQ-HTT toxicity (Hageman et al., 2010). The increased prion-re-
servoir capacity of astrocytes ultimately results in an improvement of
overall neuronal ﬁtness and in an increased lifespan of PolyQ-HTT
D.melanogaster model (Fig. S5-1C).
An alteration in neuroinﬂammation could be an additional con-
tributor to the enhanced neuroprotection due to the DNAJB6 expression
in astrocytes, which hereby might promote a more neuroprotective or
less neurotoxic pathway. Indeed, astrocytic activation has been claimed
to have both positive and negative eﬀects on the progression of PolyQ
diseases (Sofroniew and Vinters, 2010).
In conclusion, our ﬁndings support the hypothesis that increasing
astrocyte ﬁtness and functions by chaperones like DNAJB6 (tentatively
by increasing their prion-reservoir capacity) has protective signiﬁcance
in HD and possibly other protein aggregation-related NDs which show a
pathology associated with these prion-like species such as Alzheimer's
(OMIM:#104300) and Parkinson's (OMIM:#168601) (Brundin et al.,
2010; Costanzo and Zurzolo, 2013).
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nbd.2018.10.017.
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